Patent · US Active

Recombinant expression vector elements (REVES) for enhancing expression of recombinant proteins in host cells

US8410259B2 · kind B2 · utility

4Cited by

6References

12Claims

0Family size

Assignee

Abb Vie Inc. · US

Inventors

Wendy R. Gion · Charlton, US
Gerald R. Carson · Belmont, US
Hong Gao · Indianapolis, US
Yune Z. Kunes · Cambridge, US

Key dates

Filing date	Apr 29, 2011
Grant date	Apr 2, 2013
Priority date	—
Expiry date	May 15, 2031

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2830/46
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

Compositions and methods comprising recombinant expression vector elements (rEVEs) to enhance the level of expression of recombinant proteins are described. Other compositions and methods for lowering, substantially suppressing, or essentially silencing expression of a recombinant protein are also described.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.